Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?

The iShares Russell 2000 Growth ETF (IWO), with $11.51 billion in assets, offers exposure to the small-cap growth segment, primarily in healthcare (24.10%), industrials, and information technology; its expense ratio is 0.24% with a 0.83% dividend yield. IWO seeks to replicate the Russell 2000 Growth Index and has returned 9.16% over the past year but is down 1.64% YTD, exhibiting high risk with a beta of 1.14 and a 23.72% standard deviation; alternative ETFs include IJT and VBK.

Analysis

The iShares Russell 2000 Growth ETF (IWO), a passively managed fund by Blackrock with $11.51 billion in assets under management, provides exposure to the U.S. small-cap growth equity segment by seeking to track the Russell 2000 Growth Index. It carries an annual operating expense ratio of 0.24%, which is comparable to peers, and offers a 12-month trailing dividend yield of 0.83%. The ETF's portfolio is most heavily weighted towards the Healthcare sector, at 24.10%, followed by Industrials and Information Technology, with its top 10 holdings constituting 8.15% of total assets, indicating moderate concentration risk despite holding approximately 1117 securities. Performance-wise, IWO returned 9.16% over the past year as of June 11, 2025, but has experienced a year-to-date loss of 1.64%. Consistent with its small-cap growth focus, the fund exhibits a high-risk profile, evidenced by a beta of 1.14 and a three-year trailing standard deviation of 23.72%. The article notes that small-cap growth stocks inherently possess high potential but also higher risk and valuations, and tend to perform best in strong bull markets. IWO holds a Zacks ETF Rank of 3 (Hold), suggesting it is a sufficient option for its category. Alternative ETFs with lower expense ratios include the Vanguard Small-Cap Growth ETF (VBK) at 0.07% and the iShares S&P Small-Cap 600 Growth ETF (IJT) at 0.18%.

Key Decisions for Investors

• Investors considering the iShares Russell 2000 Growth ETF (IWO) should be prepared for significant volatility, as indicated by its beta of 1.14 and standard deviation of 23.72%, and note its recent year-to-date decline of 1.64% against a 9.16% one-year gain.
• Given IWO's Zacks ETF Rank of 3 (Hold) and its 0.24% expense ratio, investors should compare it with lower-cost alternatives like VBK (0.07%) or IJT (0.18%) if seeking long-term, cost-efficient exposure to small-cap growth.
• Portfolio allocation to IWO should align with an investor's outlook on the broader market cycle, particularly favoring strong bull markets where small-cap growth typically excels, and consider the fund's substantial 24.10% allocation to the Healthcare sector.